- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05709561
The Effect of Acupressure and Mindfulness to Cope With Premenstrual Syndrome (PMS) on PMS and Quality of Life
The Effect of Acupressure and Mindfulness to Cope With Premenstrual Syndrome on Premenstrual Symptoms and Quality of Life
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Centre
-
Malatya, Centre, Turkey, 44900
- Simge OZTURK
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion criteria
- Regular menstruation (between 21-35 days), being over 18 years old,
- Being single,
- Not using analgesics during menstruation,
- Not having any psychiatric diagnosis or gynecological disease (abnormal uterine bleeding, uterine fibroids, ovarian cysts, etc.),
- Not using contraceptives,
- Not having tissue deformities in the extremities and not having any health problems that can prevent physical exercise,
- A score of >110 on the PMSS scale.
Exclusion criteria
- Not participating in at least two mindfulness groups,
- Not having regular menstruation in the last 3 months,
- It is the use of analgesics during menstruation during the period of participating in the research.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Acupressure Group
Acupressure was applied to the acupressure group twice a week in the first week by the researcher.
Then, in the second week, it was observed that the students themselves applied this application twice this week under the supervision of the researcher.Then the acupressure group was asked to apply acupressure two days a week for 12 weeks, a total of 24 times.
|
acupressure application was applied 2 times a week for a total of 12 weeks and 24 times.
|
|
Active Comparator: Mindfulness Group
The researcher and students practiced mindfulness once a week for 8 weeks.
Then the students were asked to do 3 cycles of application alone every day.
mid-test was applied.
|
Mindfulness practice was applied with the students once a week for 8 weeks, accompanied by a researcher.
Then, students were asked to apply for 3 cycles.
|
|
Placebo Comparator: Plasebo Group
Acupressure and mindfulness practices were not applied to the control group and they continued their routine care.
|
No intervention was applied to the control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Premenstrual Syndrome Scale (PMSS)
Time Frame: 6 month
|
The scale consists of 44 questions.
The lowest score that can be obtained from the scale is 44, and the highest score is 220.
An increase in the score obtained from the scale indicates that the intensity of PMS symptoms increases.
A total score above 110 in the premenstrual syndrome scale indicates the presence of PMS.
|
6 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The World Health Organization Quality of Life Assessment Questionnaire
Time Frame: 6 month
|
On a five-point Likert-type scale, each A question is scored from 1 to 5, and a score can be obtained from 0-100 from the scale. An increase in the scores obtained from the scale indicates that the quality of life increases. While calculating the score of the scale, the 1st and 2nd questions are evaluated independently. In the calculation, the answers obtained from questions 3, 4, 26 and 27 are calculated by reversing. Since the scale does not have a total score, its sub-dimensions are used to evaluate the quality of life. |
6 month
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Simge ÖZTÜRK, PHD.Student, T.R. İNÖNÜ UNIVERSITY SCIENTIFIC RESEARCH AND PUBLICATION ETHICS COMMITTEE 2022/3172
- Study Director: Sermin TİMUR TAŞHAN, professor, T.R. İNÖNÜ UNIVERSITY
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022/3172
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premenstrual Syndrome
-
Haleema SadiaCompletedPremenstrual Syndrome-PMSPakistan
-
Esra ÖZERKTO Karatay UniversityCompletedPremenstrual Syndrome-PMSTurkey
-
University of Health Sciences LahoreActive, not recruitingPremenstrual Syndrome-PMSPakistan
-
Shaare Zedek Medical CenterUnknownPremenstrual Syndrome-PMS
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)RecruitingMenstrual Cycle | Premenstrual Syndrome | Premenstrual Syndrome-PMS | PMDD | Premenstrual Dysphoric Disorder (PMDD)United States
-
Cairo UniversityNot yet recruitingPremenstrual Tension
-
Cairo UniversityNot yet recruitingPremenstrual Pain
-
Activ'insideActive, not recruitingPremenstrual Syndrome-PMSItaly
-
Izmir Democracy UniversityEnrolling by invitationPremenstrual Syndrome-PMSTurkey
-
Philipps University Marburg Medical CenterLinkoeping UniversityCompletedPremenstrual Syndrome (PMS)Germany